FRESENIUS MEDICAL CARE AG/ DE0005785802 /
4/22/2025 5:29:47 PM | Chg. +0.35 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
41.99EUR | +0.84% | 57,317 Turnover: 2.38 mill. |
-Bid Size: - | -Ask Size: - | 12.14 bill.EUR | 2.42% | 22.61 |
GlobeNewswire
4/9
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors
GlobeNewswire
4/9
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors
GlobeNewswire
6/10/2024
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
GlobeNewswire
5/7/2024
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
2/4/2024
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velp...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil